Checkmate Therapeutics Co.
Latest round
- Series A
Last raised
- Nov 2020
Total raised
- $6.6M
Investors
- 3
About Checkmate Therapeutics Co.
Checkmate Therapeutics is dedicated to advancing treatment options for cancer.Checkmate Therapeutics specializes in developing innovative therapeutics for cancer and other incurable diseases. Their core offerings focus on breakthrough medicines targeted to improve patient outcomes and quality of life. The company’s therapeutics are tailored for various cancer types, addressing specific disease mechanisms.Checkmate Therapeutics generates revenue primarily through partnerships with healthcare providers and research institutions, engaging in B2B transactions to supply its therapeutics. Structured agreements facilitate the purchase of patented treatments under specific pricing plans, ensuring hospitals and clinics access the latest innovations in oncology. The company intends to target expansion into additional geographic regions, particularly in North America and Europe, by 2023. These efforts are aimed at strengthening their market position and improving access to their innovative therapies.
Who invested in Checkmate Therapeutics Co.
3 investors across 1 round
See all investors in Checkmate Therapeutics Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 12, 2020
Amount
$6.6M
Investors
Questions about Checkmate Therapeutics Co.
Who invested in Checkmate Therapeutics Co.?
Checkmate Therapeutics Co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Checkmate Therapeutics Co. raised?
Checkmate Therapeutics Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Checkmate Therapeutics Co. last raise money?
Checkmate Therapeutics Co.'s most recent round on record is a Series A, in Nov 2020.
What does Checkmate Therapeutics Co. do?
Checkmate Therapeutics is dedicated to advancing treatment options for cancer.
Where is Checkmate Therapeutics Co. headquartered?
Checkmate Therapeutics Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like Checkmate Therapeutics Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at Checkmate Therapeutics Co.'s stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series A
Raising like Checkmate Therapeutics Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.